Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage

Cell Stem Cell. 2016 Jul 7;19(1):52-65. doi: 10.1016/j.stem.2016.05.003. Epub 2016 Jun 9.

Abstract

Human BRCA1 mutation carriers and BRCA1-deficient mouse mammary glands contain an abnormal population of mammary luminal progenitors that can form 3D colonies in a hormone-independent manner. The intrinsic cellular regulatory defect in these presumptive breast cancer precursors is not known. We have discovered that nuclear factor kappaB (NF-κB) (p52/RelB) is persistently activated in a subset of BRCA1-deficient mammary luminal progenitors. Hormone-independent luminal progenitor colony formation required NF-κB, ataxia telangiectasia-mutated (ATM), and the inhibitor of kappaB kinase, IKKα. Progesterone (P4)-stimulated proliferation resulted in a marked enhancement of DNA damage foci in Brca1(-/-) mouse mammary. In vivo, NF-κB inhibition prevented recovery of Brca1(-/-) hormone-independent colony-forming cells. The majority of human BRCA1(mut/+) mammary glands showed marked lobular expression of nuclear NF-κB. We conclude that the aberrant proliferative capacity of Brca1(-/-) luminal progenitor cells is linked to the replication-associated DNA damage response, where proliferation of mammary progenitors is perpetuated by damage-induced, autologous NF-κB signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ataxia Telangiectasia Mutated Proteins / metabolism
  • BRCA1 Protein / deficiency*
  • BRCA1 Protein / metabolism
  • Breast / pathology*
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • DNA Damage*
  • Female
  • Gene Knockdown Techniques
  • Humans
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Mammary Glands, Animal / pathology*
  • Mice
  • NF-kappa B / metabolism*
  • NF-kappa B p52 Subunit / metabolism
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism
  • Progesterone / pharmacology
  • Protein Binding / drug effects
  • Sesquiterpenes / pharmacology
  • Signal Transduction / drug effects
  • Stem Cells / drug effects
  • Stem Cells / metabolism
  • Stem Cells / pathology*
  • Tumor Stem Cell Assay

Substances

  • BRCA1 Protein
  • Intracellular Signaling Peptides and Proteins
  • LC-1 compound
  • NEMO protein, mouse
  • NF-kappa B
  • NF-kappa B p52 Subunit
  • Sesquiterpenes
  • Phosphoserine
  • Progesterone
  • Ataxia Telangiectasia Mutated Proteins